Production (Stage)
Entera Bio Ltd.
ENTX
$1.86
-$0.23-11.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.27% | -18.20% | -26.99% | 7.74% | 7.90% |
| Total Depreciation and Amortization | -38.46% | -15.38% | -21.43% | -26.67% | -7.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.87% | 73.08% | 134.17% | 26.44% | -11.31% |
| Change in Net Operating Assets | 277.32% | 130.32% | -117.19% | -26.95% | -679.63% |
| Cash from Operations | 24.60% | 43.94% | -41.25% | 14.37% | -15.72% |
| Capital Expenditure | -- | 40.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 40.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 44,976.67% | -46.45% | -- | 24,220.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 44.31% | -- | -- | -- |
| Cash from Financing | 44,356.67% | -46.66% | -- | 24,220.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 750.93% | -48.75% | -40.39% | 92.35% | -13.09% |